SLNO Stock Analysis: Buy, Sell, or Hold?
SLNO - Soleno Therapeutics, Inc. Common Stock
$53.01
0.02 (0.04%)
â˛
5d:
+0.11%
30d:
+0.84%
90d:
+42.35%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Get Alerted When SLNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SLNO is fairly priced but lacks strong directional signals. At -1.8% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SLNO is fairly priced but lacks strong directional signals. At -1.8% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$108.93
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$67.64
21.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SLNO is currently trading at $53.01, which is considered fair based on recent price action. The stock's valuation (Forward PE: 8.4) is in line with its historical norms (8.9). Remarkably, the market is currently pricing in an annual earnings decline of 1.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SLNO is in a uptrend. The price is currently testing key support at $52.84. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SLNO is in a uptrend. The price is currently testing key support at $52.84. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
48/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
62.9%
Protect Your Profits
SLNO is technically overbought (RSI 78). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- NEUTRAL: Near Wall St target ($53.00)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$52.84
Resistance Level
$53.01
Current Trend
Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.43
Wall Street Target
$53.00
Profit Margin
33.7%
Valuation Discount vs History
-1.8% cheaper
PE vs Historical
8.4 vs 8.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.8%
(market-implied from PE analysis)
1-Year Target
$52.06
(-2%)
2-Year Target
$51.12
(-4%)
3-Year Target
$50.20
(-5%)
3-Yr Target (if PE normalizes)
(PE: 8â9)
$52.97
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 59.2%)
$468.15
(+783%)
Base:
(SPY PE: 8.4, Growth: 59.2%)
$178.91
(+238%)
Bear:
(PE: 7.2, Growth: 59.2%)
$152.07
(+187%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.4 to 8.9
Stabilization Target:
$55.94
(+5.5%)
PE Expansion Potential:
+5.5%
Share & Embed Analysis
Last updated: August 22, 2026 11:08 PM ET
Data refreshes hourly during market hours. Next update: 12:08 AM
Data refreshes hourly during market hours. Next update: 12:08 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLNO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 50 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$125 | 41 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 66 BUY |
|
RNA
Atrium Therapeutics, IncâĻ |
STRONG BUY
15 analysts |
$25 | 37 SELL |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$101 | 50 HOLD |
Advanced SLNO Option Strategies
Professional options setups generated by AI based on today's SLNO price and gamma walls.
